Not always the bad guys: B cells as regulators of autoimmune pathology
- PMID: 18437156
- DOI: 10.1038/nri2315
Not always the bad guys: B cells as regulators of autoimmune pathology
Abstract
When B cells react aggressively against self, the potential for pathology is extreme. It is therefore not surprising that B-cell depletion is seen as an attractive therapy in autoimmune diseases. However, B cells can also be essential for restraining unwanted autoaggressive T-cell responses. Recent advances have pointed to interleukin-10 (IL-10) production as a key component in B-cell-mediated immune regulation. In this Opinion article, we develop a hypothesis that triggering of Toll-like receptors controls the propensity of B cells for IL-10 production and immune suppression. According to this model, B cells can translate exposure to certain microbial infections into protection from chronic inflammatory diseases.
Comment in
-
B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators.Nat Rev Immunol. 2008 Jun;8(6):486-7. doi: 10.1038/nri2315-c1. Nat Rev Immunol. 2008. PMID: 18500232 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
